Active Ingredient(s): Trabectedin
FDA Approved: * October 23, 2015
Pharm Company: * JANSSEN PRODS
Category: Cancer

Trabectedin, sold under the brand name Yondelis, is an antitumor chemotherapy medication for the treatment of advanced soft-tissue sarcoma and ovarian cancer.[3][4] The most common adverse reactions include nausea, fatigue, vomiting, constipation, decreased appetite, diarrhea, peripheral edema, dyspnea, and headache.[3][4] It is sold by Pharma Mar S.A. and Johnson and Johnson. It is approved for use in the European Union, Russia,... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Yondelis .05 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 59676-610
Janssen Products, Lp